Innovent ditches low-value stake sale after investor outcry
The biopharmaceutical company had planned to sell a 20% stake in its international unit to the group’s founder, but the cheap price sparked a crisis of market confidence Key Takeaways:…
FAST NEWS: PW Medtech Shares Jump on Acquisition
The latest: Medical infusion products maker PW Medtech Group Ltd. (1358.HK) announced it will acquire 51% of Sichuan Ruijian Medical Technology Co. Ltd., another medical device maker, for a cash…
RELATED ARTICLES
-
Innovent Bio hopes for plus-sized profits from obesity drug
1801.HK -
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
-
Ascentage Pharma soars on deal with cancer drug competitor
6855.HK
-
Test results for new cancer drug take Akeso investors on wild ride
9926.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
